(The Center Square) — Patients' rights groups are praising President Donald Trump’s announcement of drug price transparency expansion as the first step toward price transparency in healthcare, stating that taxpayers deserve to know where their money is going.
Founder and chairman of PatientsRightsAdvocate. org (PRA) Cynthia Fisher told The Center Square: “We applaud President Trump, Secretaries Ken…
